bosentan anhydrous has been researched along with Heart Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Gaber, SA; Hafez, SMNA; Khalaf, HM; Rahman, SAAE; Refaie, MMM | 1 |
| Coons, JC; Kido, K | 1 |
| Díaz-Caraballo, E; García-Río, F; González-García, AE; Oliver-Ruiz, JM; Reñones, M; Sánchez-Recalde, A | 1 |
| Borst, MM; Enke, B; Ewert, R; Gilbert, N; Gruenig, E; Hoeper, MM; Lange, PE; Schulze-Neick, I; Witt, C | 1 |
| Kapoor, S | 1 |
1 review(s) available for bosentan anhydrous and Heart Diseases
| Article | Year |
|---|---|
Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
Topics: Bosentan; Endothelin Receptor Antagonists; Heart Diseases; Hemodynamics; Humans; Pulmonary Arterial Hypertension; Pyrazoles; Pyrimidines; Sildenafil Citrate; Sulfonamides | 2019 |
1 trial(s) available for bosentan anhydrous and Heart Diseases
| Article | Year |
|---|---|
Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy.
Topics: Adolescent; Adult; Antihypertensive Agents; Bosentan; Female; Heart Diseases; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prospective Studies; Sulfonamides | 2005 |
3 other study(ies) available for bosentan anhydrous and Heart Diseases
| Article | Year |
|---|---|
Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Bosentan; Cardiotoxicity; Endothelin Receptor Antagonists; Fluorouracil; Heart Diseases; Myeloid Differentiation Factor 88; Myocytes, Cardiac; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Receptors, Endothelin; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Long-term bosentan treatment of complex congenital heart disease and Eisenmenger's syndrome.
Topics: Adult; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Female; Heart Diseases; Humans; Male; Sulfonamides; Time Factors | 2009 |
Bosentan: a rapidly expanding role in the management of cardio-thoracic diseases.
Topics: Antihypertensive Agents; Blood Pressure; Bosentan; Heart Diseases; Humans; Hypertension, Pulmonary; Respiratory Function Tests; Sulfonamides; Thoracic Diseases | 2008 |